BioPharma Resources

Investigational drug · Phase 3

Vicadrostat

Also called: BI 690517

Not approved by FDA. In 5 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Heart Failure, Diabetes Mellitus, Type 2, Hypertension.

Phase 3

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 3

Industry-sponsored trials

Phase 2 and 3 trials

5

4 still active

All registered trials

20

Any phase or sponsor naming "Vicadrostat"

First trial start

2024

Jun 17, 2024

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "Vicadrostat", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Heart Failure
  • Diabetes Mellitus, Type 2
  • Hypertension
  • Cardiovascular Diseases
  • Kidney Disease, Chronic
  • Chronic Kidney Disease

Approved drugs for the same conditions: High blood pressure (hypertension) · Heart failure · Chronic kidney disease · Cardiovascular and metabolic · Kidney and urology

Largest trials

Live from ClinicalTrials.gov: studies naming "Vicadrostat" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 34 on PubMed

Also in development for Heart Failure

  • NNC0487-0111Phase 312 trials

    Novo Nordisk · Obesity, Overweight, Obstructive Sleep Apnoea

  • IRP101meta-fluorobenzylguanidine, 18F-MFBGPhase 34 trials

    Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) · Cardiovascular Diseases, Heart Failure, Ischemic Cardiomyopathy

  • ZiltivekimabPhase 34 trials

    Novo Nordisk · Acute Myocardial Infarction (AMI), Myocardial Infarction, Heart Failure

  • HiCM-188 therapyPhase 32 trials

    HELP Therapeutics Co., Ltd. · Heart Failure

  • Tasly Pharmaceutical Group Co., Ltd · Heart Failure, Chronic Heart Failure With Preserved Ejection Fraction

  • IMR-687Tovinontrine, CRD-750Phase 23 trials

    Cardurion Pharmaceuticals, Inc. · Heart Failure, Cardiovascular Diseases, Heart Diseases

  • CDR132LPhase 22 trials

    Novo Nordisk · Heart Failure

  • AZD3427Phase 21 trial

    AstraZeneca · Pulmonary Hypertension (World Health Organization Group 2), Heart Failure

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do. More from Boehringer Ingelheim.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.